Phase 2 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with invasive breast cancer (any type), confirmed by a lab test
- You are a woman aged 18–40 (any hormone receptor status), or aged 41–45 with hormone receptor-negative breast cancer
- You are expected to receive at least 4 cycles of chemotherapy containing specific drugs (paclitaxel or anthracyclines), along with medications to protect the ovaries
- You have not yet gone through menopause (including being in the early stages of menopause)
- You are able to understand the study requirements and are willing and able to follow the treatment plan
- Your general health and ability to carry out daily activities is good (confirm with trial site)
- You are willing to take part and have signed a consent form
Who may not be able to join:
- You have used any vaginal medication in the 3 months before joining the study
- You have used any antibiotic or anti-infection medication in the 3 months before joining the study
- You currently have an active infection in the genital area
- You have previously had another type of cancer
- For any reason, you are unable to complete all follow-up appointments and treatment as planned by your doctor
- Certain blood test results or a heart scan show that your liver, kidneys, or heart are not functioning well enough (confirm specific values with trial site)
- You have a serious blood clotting disorder, a severe ongoing illness, or an infection that cannot be controlled
- You are not able to make independent decisions for yourself, or you have a mental health condition or addiction that the study doctors feel would make participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Vaginal PH; Functional Assessment of Cancer Therapy - Endocrine Symptoms (FACT-ES)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.